Barrett's Esophagus Clinical Trials
A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 1351 clinical trials
Diffusion MRI for Head and Neck Cancer
Previous studies have shown that both diffusion coefficient D and diffusional kurtosis coefficient K are promising imaging markers of (i) cell viability which can be used for evaluation of early treatment response. However, it is often underappreciated that these dMRI metrics are not fixed constants, but rather functions of the …
- 0 views
- 27 May, 2025
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.
- 0 views
- 19 Feb, 2024
- 1 location
ADORED-Allergic Disease Onset Prevention Study
STMC-103H is a live biotherapeutic product (LBP) containing a consortium of intestinal bacteria that may impact the incidence of allergic sensitization and disease in neonates and infants at risk for developing allergy and asthma. STMC-103H is an oral capsule containing powder which will be mixed with a small amount of …
- 0 views
- 13 Jan, 2025
- 9 locations
A5418 Study of Tecovirimat for Human Monkeypox Virus (STOMP)
Participants will be seen at day 57 to assess for possible recrudescence of infection (i.e., new lesions occurring after initial resolution of disease.
- 0 views
- 19 Feb, 2024
- 1 location
test website import(please dont visit)
For more information and details, they can head over to the website of Vedantu. The Vedantu app can also be downloaded and skimmed through for more ease while studying...................................................................................................................
- 0 views
- 27 Sep, 2024
- 2 locations
Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)
Is there any hesitancy to get the vaccine and what are the reasons? This information will be used to help keep the school open and the students and staff safe. Eligible participants are those that work at the Mary Cariola Center (MCC) and interact with the students at MCC who …
- 0 views
- 19 Feb, 2024
v6.11_prescreener_study(please don't touch)
Intense stress has harmful effects on the body, contributing to various disorders. Breast cancer patients experience a build-up of stress due to their diagnosis and treatments. Stress can cause epigenetic changes in a cellular level (such as accelerated increase in biological age) that may negatively affect oncological treatments.This study aims …
- 0 views
- 19 Feb, 2024
- 2 locations
Study on the Visual Condition in Parkinson's Disease
Non motor symptoms and signs in Parkinson's disease (PD) also include a series of visual deficits; deepening these aspects could be useful for a better management of symptoms, to standardize a specific protocol for the issues related to vision and also to understand how these aspects are important for the …
- 0 views
- 19 Feb, 2024
- 2 locations
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients
Primary Objective: To determine the effect of venglustat on the rate of total kidney volume (TKV) growth (Stage and estimated glomerular filtration rate (eGFR) decline in patients at risk of rapidly progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) (Stage 2). Secondary Objectives: To determine the effect of venglustat on the …
- 0 views
- 19 Feb, 2024
- 81 locations
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps (CEREN2)
Study details include:The study duration per participant (4-week screening, 52-week treatment, 20-week safety follow-up) will be up to 76 weeks. For participants transitioning to the LTS18420 study, the study duration will be 56 weeks.The treatment duration will be up to 52 weeks.
- 0 views
- 02 Jun, 2025